C40H34CaF2N2O8
748.8 g/mol
APIDanger
Vidofludimus calcium anhydrous
CAS1354012-90-0
Category
API
Compound Class
Organometallic
Primary Use
Pharmaceutical Raw Material
Vidofludimus calcium anhydrous is the calcium salt form of vidofludimus, an orally bioavailable compound that inhibits dihydroorotate dehydrogenase (DHODH). It is used in pharmaceutical research and manufacturing as an active pharmaceutical ingredient for its potential anti-inflammatory, immunomodulating, and anti-viral properties.
dihydroorotate dehydrogenase inhibitor research compoundpharmaceutical raw material for anti-inflammatory and immunomodulating studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1354012-90-0
Related Compounds
ReferenceSame Category
Cabazitaxel N-1
CAS1354900-66-5
pharmaceutical raw material
ReferenceSame Category
Rifamycin s
CAS13553-79-2
pharmaceutical raw material
ReferenceSame Category
Pneumocandin B0
CAS135575-42-7
pharmaceutical raw material
ReferenceSame Category
2-(((2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy)methoxy)-3-hydroxypropyl D-valinate
CAS1356353-76-8
pharmaceutical raw material
Referencestereoisomer of
Vidofludimus
CAS717824-30-1
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H360May damage fertility or the unborn child
H413May cause long lasting harmful effects to aquatic life
Identifiers
IUPAC Name
calcium bis(2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylate)
InChIKey
KWSJBFAXOPFZSO-UHFFFAOYSA-L
SMILES
COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.[Ca+2]
Synonyms (4)
- Vidofludimus Calcium
- Vidofludimus hemicalcium